Site icon OncologyTube

TKI Neoadjuvant: Is Complete Pathological Response Possible?- Targeted Therapies in Lung Cancer 2023

Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This includes a Q&A with the audience and a presentation by a patient advocate, Ivy Elkins.

In this video, Drs. Stephen Liu and Misako Nagasaka discuss current trends toward neoadjuvant TKI treatment options.

For more, please visit http://cancerGRACE.org/.
To join the conversation, visit https://cancergrace.org/forum.

BenSound File Name: Sweet (BenSound.com)
BenSound License #: DSSHUIYGV4VQCETM

Thank you to our sponsors: #Takeda #Janssen #Lilly #Genentech #Mirati #ExactSciences #BMS #GEHealthcare.

Exit mobile version